Vaccinia virus and tuberculin reactivity
Smithwick, E.M.; Steiner, M.; Quick, J.D.
Pediatrics 50(4): 660-661
1972
ISSN/ISBN: 0031-4005 PMID: 5073018 Document Number: 54361
Document emailed within 1 workday
Related Documents
Topa, P.K.; Rao, K.V. 1976: Extraction of vaccinia virus and purification of vaccinia elementary body suspension with Mafron 11 Indian Journal of Medical Research 64(10): 1421-1431Sitnikov, B.S.; Gendon, I.Z. 1970: "Rescue" of the rct40 plus-marker of vaccinia virus in different methods of inactivation of the donor virus Voprosy Virusologii 15(3): 278-283
Haishi, S.; Imai, H.; Hirai, K.; Igarashi, A.; Kato, S. 1989: Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus Acta Virologica 33(6): 497-503
Sottnek, H.M.; Cassel, W.A.; Campbell, W.G. 1975: The pathogenesis of Vaccinia virus toxicity. I. the role of virus-platelet interaction Laboratory Investigation; a Journal of Technical Methods and Pathology 33(5): 514-521
Wojcik, J. 1995: Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector Acta Microbiologica Polonica 44(2): 191-196
Sviatchenko, V.A.; Agapov, E.V.; Urmanov, I.Kh.; Serpinskiĭ, O.I.; Frolov, I.V.; Kolykhalov, A.A.; Ryzhikov, A.B.; Netesov, S.V. 1993: The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus Voprosy Virusologii 38(5): 222-226
Bruckner, S.; Ciugarin, M.; Cotarcea, S.; Istodor, N. 1972: Double infection with vaccinia virus and echo virus Annales de Pediatrie 19(3): 253-255
Cherney, T.M.; Schultz, R.D. 1996: Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes American Journal of Veterinary Research 57(6): 812-818
Umekita, T.; Yamamoto, M. 1988: Analysis of the results of tuberculin reactions among primary and middle school students in K city, Kagoshima Prefecture, with special emphasis on the comparison of the intensity of tuberculin hypersensitivity in repeated tuberculin tests Kekkaku: 63(2): 93-99
Zarling, J.M.; Eichberg, J.W.; Moran, P.A.; McClure, J.; Sridhar, P.; Hu, S.L. 1987: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins Journal of Immunology 139(4): 988-990
Chernushenko, E.F.; Kogosova, L.S.; Petrashenko, A.I. 1983: Comparative evaluation of immunological reactivity in persons with hyperergic and normoergic skin reactions to tuberculin Problemy Tuberkuleza 9: 18-23
Muscoplat, C.C.; Thoen, C.O.; McLaughlin, R.M.; Thoenig, J.R.; Chen, A.W.; Johnson, D.W. 1975: Comparison of lymphocyte stimulation and tuberculin skin reactivity in Mycobacterium bovis-infected Macaca mulatta American Journal of Veterinary Research 36(5): 699-701
Repo, H.; Kostiala, A.A.; Kosunen, T.U. 1980: Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation Clinical and Experimental Immunology 39(2): 442-448
Beaud, G.; Mars, M.; Vassef, A. 1987: Vaccinia virus as a vector Developments in Biological Standardization 66: 49-54
Ghendon, Y.Z.; Rozina, E.E.; Marchenko, A.T. 1973: On the "neuropathogenicity" mechanism of vaccinia virus Acta Virologica 17(2): 169
Mückter, H.; Sous, H.; Poszich, G.; Nijssen, J. 1971: Rifampicin inhibition of vaccinia virus in mice Arzneimittel-Forschung 21(10): 1571-1572
Korbecki, M.; Bankowski, A.; Filczak, K.; Klimek, A. 1985: Dipyridamole as an inhibitor of vaccinia virus replication Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 1: 29-32
Chen, H.; Padmanabhan, R. 1994: A modified method for isolation of recombinant vaccinia virus Biotechniques 17(1): 40; 42
Kochneva, G.V.; Babkina, I.N.; Lupan, T.A.; Grazhdantseva, A.A.; Iudin, P.V.; Sivolobova, G.F.; Shvalov, A.N.; Popov, E.G.; Babkin, I.V.; Netesov, S.V.; Chumakov, P.M. 2013: Apoptin enhances the oncolytic activity of vaccinia virus Molekuliarnaia Biologiia 47(5): 842-852
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174